General MedicationsINJECTIONStandard
LEVOCARNITINE
LEVOCARNITINE
Standard Dose
200MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LEVOCARNITINE is listed in Drugs@FDA under application 217430 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOCARNITINE Form and strength INJECTABLE;INJECTION - 200MG/ML Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2025-06-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVOCARNITINE is listed in Drugs@FDA under application 217430 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOCARNITINE Form and strength INJECTABLE;INJECTION - 200MG/ML Sponsor DEVA HOLDING AS Submission history Latest submission status date: 2025-06-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.